Technological innovation promotes healthy life for mankind
Market/Consultation
1. Biomarkers and Platform Identification
2. Raw Material Screening & Intermediate
Raw Material Sourcing & Customization Services
End-to-end one-stop solution from R&D to large-scale production
From raw material screening, raw material customization services, intermediate product production, test kit formulation development empowerment, test kit process optimization to capacity expansion and regulatory registration, as well as OEM services, we provide customers with comprehensive end-to-end in vitro diagnostic reagent R&D and OEM processing solutions.
Outsourced Development & Process Validation Services
3. Formulation Development
4. Process Optimization
Contract Manufacturing Services
6. Scale-Up Production
5. Regulatory Compliance
Commissioned Registration Services
Comprehensive solutions for the industrialization process of IVD test kits
We have a complete R&D and process transformation laboratory
laboratory
IVD Future Academy
IVD Future Academy (Senior Engineer Training Program for In Vitro Diagnostic Reagent Industry) aims to help global in vitro diagnostic companies cultivate professional and technical talents in the research and development, production and regulatory registration of technical platforms such as lateral flow, molecular diagnosis, and chemiluminescence. The training class is taught by process engineers with rich theoretical knowledge and more than 20 years of R&D and production experience. The teaching method that combines theoretical knowledge with laboratory practice provides professional and systematic on-the-job training for the IVD industry.
Expert Team
Our team of scientists and engineers consists of industry elites and senior experts, covering the mainstream technology of in vitro diagnostics from biochemical immunology, POCT, molecular diagnosis to chemiluminescence. The expert team is familiar with the regulatory systems of global markets such as FDA, CE-IVD, NMPA, etc., and provides efficient industry empowerment services for global IVD customers.
Customer Voice
Customer recognition is our greatest motivation to keep moving forward, and we will continue to be committed to the advancement and development of medical technology.
"DxPartner's CDMO services have helped us accelerate our R&D and industrialization process and greatly improved the efficiency of innovation. They have become an important ecological partner of the IVD industry."
David Li (Deputy General Manager, Marketing Director, Petit Pet Products Group)
"The IVD Future Academy hosted by Merck Group and DxPartner is an important vocational skills training for the in vitro diagnostic industry. It can help practitioners master the key points and systems of process development through theoretical courses and practical training."
Li Kai (Vice President, Chief Scientist, R&D Director, Senior Engineer, Yahuilong Co., Ltd.)
"In the post-epidemic era, IVD industry companies are facing a complex domestic and international environment and are in urgent need of high-quality partners like DxPartner to further improve their layout, make judgments and adjustments quickly and accurately, and safeguard the rapid development of their companies."
Jiang Xiwen (Deputy General Manager, Chief Scientist, R&D Director, and Senior Engineer of Guangzhou Daan Gene Co., Ltd.)
Our Strategic Partners
In 2022, DxPartner signed a strategic partnership agreement with Merck Life Sciences, becoming Merck, a German technology company with a history of more than 350 years, an ecological partner in the field of in vitro diagnostic CDMO.
The common choice of global IVD companies
To date, DxPartner has provided professional services including diagnostic reagent development, processing, customized raw materials, and industry training to more than 100 in vitro diagnostic manufacturers.
